Accentrix Solution for Injection
Marketer
Novartis India Ltd
Salt Composition
Ranibizumab (10mg/ml)
Overview Accentrix Solution for Injection
OcuGen injection treats diabetic retinopathy, macular degeneration, and macular edema. It works by inhibiting abnormal blood vessel growth and leakage in the eye, preventing vision impairment. Administered directly into the eye by an ophthalmologist only – self-injection is strictly prohibited. Potential side effects include conjunctival bleeding, ocular pain, floaters, elevated intraocular pressure, and eye irritation. Report worsening or persistent side effects to your physician immediately. Avoid driving after injection due to possible temporary visual blurring. A patient assistance program, facilitated by Tata 1mg, is available in India. Consult your doctor or call (1800-102-1618) for program details.
Primary Ingredients of Accentrix Solution for Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Accentrix Solution for Injection
Eye conditions associated with diabetes, wet macular degeneration, and retinal vein occlusion-related macular swelling.
Major Benefits of Accentrix Solution for Injection:
Medical professionals will instruct you on the proper administration of this medication.
Common Side effects of Accentrix Solution for Injection:
- Conjunctival hemorrhage
- Eye pain
- Increased intraocular pressure
- Foreign body sensation in eyes
- Blurred vision
- Nausea
- Dry eye
- Eye itching
- Cataract
- Vitreous floaters
- Vitreous detachment
- Intraocular inflammation
- Eye irritation
- Increased lacrimation
- Eyelid inflammation
- Ocular hyperemia
- Retinal disorder
- Maculopathy
- Eye discomfort
- Posterior capsule opacification
- Injection site hemorrhage
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Anemia (low number of red blood cells)
- Joint pain
- Renal failure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Gastro-esophageal reflux disease
- Hypercholesterolemia (high cholesterol)
- Bronchitis (inflammation of the airways)
How to use Accentrix Solution for Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
How Accentrix Solution for Injection works:
Inhibiting vascular endothelial growth factor (VEGF), Accentrix Injectable Solution acts as an anti-angiogenesis agent. This mechanism prevents the formation and permeability of diseased ocular blood vessels, thereby mitigating potential vision impairment.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between Accentrix Solution for Injection and alcohol is currently undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Accentrix Solution for Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Accentrix is likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Following administration of Accentrix Solution for Injection, temporary blurred vision may occur. Refrain from driving until your vision has returned to normal.
KidneySAFE IF PRESCRIBED
The injectable formulation of Accentrix likely poses minimal risk to individuals with impaired renal function. Preliminary evidence indicates dose modification for Accentrix injection may be unnecessary in this population. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Accentrix injectable solution appears to be well-tolerated in individuals with hepatic impairment. Preliminary findings indicate dose modification may not be necessary for this population. Physician consultation is recommended.
What if you forget to take Accentrix Solution for Injection :
Omit a dose of injectable Accentrix Solution? Seek your physician's advice.
Facts to Know About Accentrix Solution for Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Type of Therapy | Ophthalmology |
| Actions | AMD treatment with a VEGF inhibitor |
3,018 People bought this recently